BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22659191)

  • 1. Management of complex pelvic masses using a multivariate index assay: a decision analysis.
    Kim KH; Zsebik GN; Straughn JM; Landen CN
    Gynecol Oncol; 2012 Sep; 126(3):364-8. PubMed ID: 22659191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass.
    Havrilesky LJ; Dinan M; Sfakianos GP; Curtis LH; Barnett JC; Van Gorp T; Myers ER
    J Natl Cancer Inst; 2015 Jan; 107(1):322. PubMed ID: 25515232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of a multivariate index assay compared to modified American College of Obstetricians and Gynecologists criteria and CA-125 in the triage of women with adnexal masses.
    Forde GK; Hornberger J; Michalopoulos S; Bristow RE
    Curr Med Res Opin; 2016; 32(2):321-9. PubMed ID: 26588255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative assessment of ovarian tumors using a modified multivariate index assay.
    Abdurrahman HA; Jawad AK; Alalalf SK
    J Ovarian Res; 2018 May; 11(1):41. PubMed ID: 29843758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass.
    Bristow RE; Hodeib M; Smith A; Chan DW; Zhang Z; Fung ET; Tewari KS; Munroe DG; Ueland FR
    Am J Obstet Gynecol; 2013 Dec; 209(6):581.e1-8. PubMed ID: 23942039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ovarian imaging on the clinical interpretation of a multivariate index assay.
    Goodrich ST; Bristow RE; Santoso JT; Miller RW; Smith A; Zhang Z; Ueland FR
    Am J Obstet Gynecol; 2014 Jul; 211(1):65.e1-65.e11. PubMed ID: 24530816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
    Coleman RL; Herzog TJ; Chan DW; Munroe DG; Pappas TC; Smith A; Zhang Z; Wolf J
    Am J Obstet Gynecol; 2016 Jul; 215(1):82.e1-82.e11. PubMed ID: 26970494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
    Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
    Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients.
    Eskander RN; Carpenter BA; Wu HG; Wolf JK
    Curr Med Res Opin; 2016 Jun; 32(6):1161-5. PubMed ID: 27052730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-operative evaluation of ovarian tumors by risk of malignancy index, CA125 and ultrasound.
    Arun-Muthuvel V; Jaya V
    Asian Pac J Cancer Prev; 2014; 15(6):2929-32. PubMed ID: 24761927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of an expert examiner and different ultrasound models in the diagnosis of ovarian cancer.
    Meys EMJ; Jeelof LS; Ramaekers BLT; Dirksen CD; Kooreman LFS; Slangen BFM; Kruitwagen RFPM; Van Gorp T
    Eur J Cancer; 2018 Sep; 100():55-64. PubMed ID: 29957561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-risk multivariate index assay scores, physician referral and surgical choices in women with adnexal masses.
    Dunton CJ; Eskander RN; Bullock RG; Pappas T
    Curr Med Res Opin; 2020 Dec; 36(12):2079-2083. PubMed ID: 33107342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
    Bristow RE; Smith A; Zhang Z; Chan DW; Crutcher G; Fung ET; Munroe DG
    Gynecol Oncol; 2013 Feb; 128(2):252-9. PubMed ID: 23178277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study.
    Karlsen MA; Fagö-Olsen C; Høgdall E; Schnack TH; Christensen IJ; Nedergaard L; Lundvall L; Lydolph MC; Engelholm SA; Høgdall C
    Tumour Biol; 2016 Sep; 37(9):12619-12626. PubMed ID: 27440204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
    Miller RW; Smith A; DeSimone CP; Seamon L; Goodrich S; Podzielinski I; Sokoll L; van Nagell JR; Zhang Z; Ueland FR
    Obstet Gynecol; 2011 Jun; 117(6):1298-1306. PubMed ID: 21555961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis.
    Bristow RE; Santillan A; Diaz-Montes TP; Gardner GJ; Giuntoli RL; Meisner BC; Frick KD; Armstrong DK
    Cancer; 2007 Apr; 109(8):1513-22. PubMed ID: 17354232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?
    Yanaranop M; Anakrat V; Siricharoenthai S; Nakrangsee S; Thinkhamrop B
    Gynecol Obstet Invest; 2017; 82(1):47-53. PubMed ID: 27197526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
    Cadish LA; Shepherd JP; Barber EL; Ridgeway B
    Am J Obstet Gynecol; 2017 Nov; 217(5):603.e1-603.e6. PubMed ID: 28619689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.